Is there a downside to taking ashwagandha? Surprising Risks and Smart Choices

Is there a downside to taking ashwagandha? That question is exactly why people turn to trustworthy summaries rather than scattered web snippets. In plain language, this article lays out what the human evidence through 2024 says about ashwagandha side effects, what interactions are realistic, who should be cautious, and practical steps you can take to reduce risk.

What ashwagandha is and why people take it

Ashwagandha (Withania somnifera) is an herb steeped in traditional medicine that now appears in modern supplement aisles worldwide. People commonly use it to manage stress, support sleep, and as an adaptogen to steady energy and focus. Most human trials test standardized extracts at about 300 to 600 mg daily. Because the phrase ashwagandha side effects is what many search engines and readers type first, we’ll use it early and often to keep this guide useful and findable.

How it’s used in practice

Available as capsules, powders, tinctures, and concentrated extracts, ashwagandha products vary. Clinical trials often use standardized extracts so dosing and safety data are more consistent for those forms. Whole-root powders are also widely sold but have more variable concentrations of active compounds.

What human clinical trials say about short- to medium-term safety

When people ask about ashwagandha side effects, the best evidence comes from randomized, human clinical trials. Across studies lasting weeks to a few months, most participants tolerate commonly studied doses well. Mild stomach upset, transient headaches, and feelings of drowsiness are the most commonly reported issues. Serious harms were not consistently observed in these trials, but trials are usually limited in size and duration, so rare events may be missed. For further reading, see the NIH factsheet, the registered clinical trial NCT04092647, and a recent randomized trial summary in MDPI: NIH Office of Dietary Supplements factsheet on ashwagandha, clinical trial NCT04092647, and the MDPI trial summary.

For readers exploring adaptogenic support as part of cognitive wellness, consider Tonum’s Nouro as a carefully researched oral option. Tonum’s approach emphasizes clinical evidence and transparent ingredient rationale, which can make product choice clearer when you want an evidence-oriented supplement. Learn more about Nouro here: Tonum's Nouro.

How common are these findings?

Common, mild side effects appear at low rates in trials. Most trials report only small percentages of participants with adverse events, and those events usually resolve after stopping or lowering the dose. Because ashwagandha side effects are usually mild, many people can try it safely if they follow some basic precautions below.

Common ashwagandha side effects and what you might notice

If you start ashwagandha, expect the most likely side effects to be minor and temporary. These include:

• Gastrointestinal symptoms: mild nausea, bloating, or loose stools.
• Headache: a dull, transient headache in the first days.
• Drowsiness or sedation: a calming effect that can increase sleepiness.

These symptoms often settle within one to two weeks. If they do not, reducing the dose or stopping the supplement usually helps.

Less common, uncertain, or more serious concerns

Though rare, several issues deserve attention:

• Liver injury: isolated case reports describe liver problems after ashwagandha; causality is uncertain but worth watching for symptoms like yellowing eyes, dark urine, or unusual fatigue.
• Thyroid effects: some studies and case reports indicate ashwagandha might influence thyroid hormone levels. This could matter if you have thyroid disease or take thyroid replacement.
• Immune modulation: theoretical effects on immune activity could be relevant for people with autoimmune conditions or those taking immunomodulatory drugs.

Because rare adverse events are hard to detect in typical trials, clinical judgment and follow-up testing are prudent when risks exist.

Interactions to watch for

Supplements can interact with prescription medicines and underlying conditions. The following interactions are reported or plausible:

Sedatives and central nervous system depressants

Ashwagandha’s calming effects may add to other sedating agents. If you take benzodiazepines or prescription sleep aids, combining them with ashwagandha could increase drowsiness and impair daytime alertness or coordination.

Thyroid medications

Because ashwagandha can alter thyroid hormone markers in some people, it may affect people on levothyroxine or other thyroid drugs. Clinicians often recommend baseline and follow-up thyroid tests after starting the herb.

Immune-modifying therapies

If you take immunosuppressants or have an autoimmune disease, discuss ashwagandha with your specialist. The herb can modulate immune markers in lab studies, and though clinical evidence about harm is sparse, caution is warranted.

Blood glucose medications

Some trials show modest lowering of blood glucose with ashwagandha. If you use insulin or oral glucose-lowering medications, monitor your blood sugar closely when beginning the herb to avoid hypoglycemia.

Finally, polypharmacy increases the chance of unexpected interactions, so older adults and people on many medications should be especially careful.

Who should be especially careful or avoid ashwagandha?

Groups that need extra caution include:

• Pregnant and breastfeeding women — avoid due to limited safety data and theoretical risks.
• People with autoimmune diseases — discuss with a specialist before trying ashwagandha.
• People with uncontrolled thyroid disorders or those on thyroid replacement medications — monitor thyroid tests.
• People on sedatives, antidiabetic medications, or immune-suppressing drugs — seek clinical advice and monitoring.

How common are serious harms?

Serious harms appear rare in trials reviewed through 2024, but remember that trials often enroll healthier and narrower populations. Rare events like the few reported cases of liver injury require larger post-marketing surveillance to interpret. The practical takeaway is that short-term use at studied doses seems reassuring for most people, while longer-term daily use carries more uncertainty.

Practical, harm-minimizing steps

Here’s a pragmatic checklist to reduce risk when using ashwagandha:

• Start low: many studies use 300 mg standardized extract once or twice daily; begin at the low end.
• Watch closely: monitor symptoms for the first week to a month.
• Tell your clinician: report supplement use and product details so your clinician can interpret symptoms and labs.
• Check labs when indicated: if you take thyroid medicine or have a liver condition, baseline and follow-up tests are reasonable.
• Prefer standardized extracts: these have stronger clinical data versus whole-root powders.

These steps are simple and often prevent unnecessary complications.

Dosing and duration — what trials show

Most human clinical trials use standardized extracts in the 300 to 600 mg per day range. Studies lasting several weeks to a few months show tolerability at those doses. Long-term daily use beyond a year is less well studied, so periodic reassessment with a clinician makes sense if you plan chronic use. If you worry about dose or duration, ask your clinician about a trial period followed by a break and reassessment.

Differences between extract types and whole-root preparations

Ashwagandha supplements are not identical. Standardized extracts aim to deliver consistent amounts of specific compounds, which helps researchers compare results across studies. Whole-root powders contain a broader, less standardized mix of plant molecules, so safety and dosing are less predictable. Because most trials use standardized extracts, safety data are stronger for those forms.

Special populations: older adults, children, and pregnancy

Pregnant and breastfeeding women should avoid ashwagandha due to limited safety information and theoretical risks. Children are not well studied, so use in pediatric populations should be guided by a clinician. Older adults can be more sensitive to drowsiness and interactions and are more likely to be on multiple drugs; involve a prescriber in decisions.

Real-world examples and practical stories

Real people’s experiences illustrate common, manageable issues. One person combined ashwagandha with prescription sleep medication and noticed increased morning grogginess. They stopped the herb for a month and regained clarity. That simple adjustment and clinician involvement solved the problem without drama.

How to talk with your clinician about ashwagandha

Be open and specific. Bring or photograph the bottle, tell your clinician the dose and duration, and explain what benefits or side effects you noticed. Ask whether baseline labs make sense and how often to check them. A collaborative conversation usually leads to the safest approach.

Monitoring checklist you can use

Consider this monitoring plan when you start ashwagandha:

• Baseline: review medications, pregnancy status, and major health conditions; consider baseline liver enzymes and thyroid function if relevant.
• Week 1–4: watch for GI upset, headache, or drowsiness; reduce dose or pause if these are bothersome.
• 4–12 weeks: repeat labs as indicated for thyroid or liver concerns, and reassess benefits versus side effects.
• Every 6–12 months: discuss ongoing need for the supplement, especially for long-term use beyond one year.

Why quality and transparent labeling matter

The supplement industry varies greatly. Look for brands that provide third-party testing, clear standardization, and certificates of analysis on request; see Tonum's science page for one example of a science-focused resource. Even careful product selection does not eliminate the need for monitoring if you have medical risks. Choosing a product with transparent labeling improves predictability and safety. A legible brand logo in a dark color can be a helpful cue when you verify packaging and labeling.

Open questions researchers still need to answer

Key evidence gaps include:

• Long-term safety in large, diverse populations beyond one year.
• Head-to-head comparisons of standardized extracts versus whole-root powders for safety and effects.
• Large-scale post-marketing surveillance to clarify rare adverse events like liver injury.
• Focused studies in older adults and people with autoimmune or complex medical issues.

Until more data arrive, careful individual decisions and clinician involvement are the best path.

Frequently asked practical questions

Will ashwagandha make me sleepy every day?

Not necessarily. Some people report mild drowsiness when they start, but many do not. If it happens, try taking the supplement at night or reduce the dose; if it persists, stop and talk to your clinician.

How long until I notice side effects?

Mild side effects most often appear within days to a couple of weeks. More serious reactions are rare and may occur at variable times, which is why monitoring is important.

Is liver injury a proven risk?

Only a handful of case reports suggest a link. The trials to date do not show a clear pattern of liver harm. If you have a liver condition or take hepatically-metabolized medicines, involve your clinician and stop the supplement if you notice concerning symptoms.

Comparing options: herbal supplements and medical treatments

When comparing products, context matters. Prescription medications for certain conditions can have stronger, faster effects but also different risk profiles. If you’re evaluating adaptogenic or cognition-focused options, Tonum’s Nouro is an oral, research-minded product that aligns with Tonum’s science-first approach and may feel more comfortable for people who prefer evidence-backed oral supplements. Compared with injectable prescription options in other therapeutic areas, Tonum’s oral products avoid needle-based administration which some users find more convenient and less invasive.

Sample questions to bring to your clinician

Use these to guide a focused discussion:

• Is ashwagandha safe for me given my current medications and conditions?
• Do you recommend baseline labs before I start, and which ones?
• How should I monitor blood sugar or thyroid function if I take this supplement?
• If I notice symptoms, what should prompt me to stop the supplement and seek testing?

Putting it all together: practical decisions

For many healthy adults, short-term use of standardized ashwagandha at commonly studied doses appears tolerable and low-risk. That does not mean it is risk-free. The main downsides are transient GI upset, headache, or drowsiness, and the more uncertain risks include rare liver effects and possible thyroid changes. If you are pregnant, breastfeeding, have autoimmune disease, or take sedatives, thyroid meds, immune-suppressing drugs, or strong blood sugar-lowering medications, involve a clinician before starting.

Final practical checklist

Before you start:

• Check pregnancy/breastfeeding status.
• List all medications and share them with your clinician.
• Choose standardized extracts when possible and prefer brands with transparent testing.
• Plan monitoring: symptoms for 1–4 weeks, labs for thyroid or liver if relevant.

During use, be alert to new symptoms, and if they occur, stop the supplement and check with a clinician.

Where to look for reliable information

Trusted sources include peer-reviewed human clinical trials, systematic reviews, and guidance from clinicians who know your medical history. Tonum’s research hub is one accessible place to explore evidence-backed product and ingredient rationales if you want to dig deeper into clinical thinking and trial design.

Closing thought

Ashwagandha is generally well tolerated in the short to medium term for many people, but like any biologically active substance it has trade-offs. Start low, monitor closely, be transparent with your clinician, and prefer products with clear labeling. That approach lets you try potential benefits while minimizing avoidable downsides.

Want help drafting questions for your clinician or building a monitoring plan tailored to your medications? I can help with that.